GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksORPH.L Share News (ORPH)

  • There is currently no data for ORPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Cathal Friel-led Poolbeg Pharma set to float on AIM

Thu, 17th Jun 2021 14:34

(Sharecast News) - Infectious disease specialist Poolbeg Pharma is to list on the London Stock Exchange's junior market, AIM, with a view to raising the funds needed to develop its product pipeline.
The outfit is the third life science firm from the Cathal Friel and Raglan Capital stable, alongside Amryt and Open Orphan.

Four days before, Open Pharma had announced its intention to distribute Orph Pharma Company Limited's share capital in specie.

"Poolbeg's approach to asset development should result in good licensing opportunities and excellent returns in a relatively short period of time with substantially less risk than the traditional biotech model and allow for regular investor newsflow," Poolbeg's non-executive chairman, Cathal Friel said.

Friel was also the executive chairman of Open Orphan.

The total addressable Infectious Disease market was put by Poolbeg at $250bn by 2025.

The company also noted how the estimated cost of the Covid-19 pandemic measured by lost economic output and reduced health amounted to 90% of US gross domestic product.

Its main asset was POLB 001, a Phase II ready small molecule immunomodulator for severe influenza.

The value of the addressable market for severe flu was put at $800m.

Poolbeg also had a vaccine discovery platform to seek out new vaccines which might generate "significant" shareholder value.

It also owned the PredictViral Biomarker platform for predicting severe disease, which the firm said held the "potential to transform the way infectious diseases are treated".

There was also a pipeline of further assets for acquisition post-IPO.
More News
10 Aug 2020 10:56

IN BRIEF: Open Orphan Wins Contract With "Top 3" Pharma Firm

IN BRIEF: Open Orphan Wins Contract With "Top 3" Pharma Firm

Read more
4 Aug 2020 19:16

UK TRADING UPDATE SUMMARY: Brickability Recovering Well From Pandemic

UK TRADING UPDATE SUMMARY: Brickability Recovering Well From Pandemic

Read more
4 Aug 2020 11:25

Open Orphan signs new pharma trial contract with Carna

(Sharecast News) - Pharmaceutical services company Open Orphan announced the signing of a new contract with Carna Bioscience on Tuesday, for a first-in-human clinical pharmacology trial.

Read more
28 Jul 2020 15:25

IN BRIEF: Open Orphan Wins Covid-19 Vaccine Study Contract

IN BRIEF: Open Orphan Wins Covid-19 Vaccine Study Contract

Read more
28 Jul 2020 10:29

Open Orphan to conduct in-human trials on Covid-19 intranasal vaccine candidate

(Sharecast News) - Pharmaceutical services company Open Orphan has secured a contract with Codagenix to conduct a first in-human trial evaluating the safety and immunogenicity of a single-dose, intranasal SARS-CoV-2 vaccine candidate.

Read more
15 Jul 2020 11:47

UK TRADING UPDATE SUMMARY: Finsbury Food's Annual Revenue Set To Fall

UK TRADING UPDATE SUMMARY: Finsbury Food's Annual Revenue Set To Fall

Read more
7 Jul 2020 16:35

UK TRADING UPDATE SUMMARY: Retailer Sosandar In Quarterly Revenue Jump

UK TRADING UPDATE SUMMARY: Retailer Sosandar In Quarterly Revenue Jump

Read more
7 Jul 2020 12:32

Open Orphan signs three new contracts with third parties

(Sharecast News) - Pharmaceutical services company Open Orphan announced on Tuesday that, as part of opening its hVIVO laboratory services to third parties, it has signed three new contracts with third parties.

Read more
15 Jun 2020 13:57

IN BRIEF: Successful Open Orphan AGS-v Mosquito Saliva Vaccine Trial

IN BRIEF: Successful Open Orphan AGS-v Mosquito Saliva Vaccine Trial

Read more
11 Jun 2020 13:23

UK TRADING UPDATE SUMMARY: Churchill China Sales Hit By Virus

UK TRADING UPDATE SUMMARY: Churchill China Sales Hit By Virus

Read more
11 Jun 2020 09:05

Open Orphan secures major contract with mystery vaccine developer

(Sharecast News) - Pharmaceutical services company Open Orphan has signed a major contract with an unnamed vaccine developer.

Read more
4 Jun 2020 13:19

UK TRADING UPDATE SUMMARY: Open Orphan Launches Covid Testing Service

UK TRADING UPDATE SUMMARY: Open Orphan Launches Covid Testing Service

Read more
4 Jun 2020 08:51

Open Orphan launches Covid antibody testing service

(Sharecast News) - Contract research organisation Open Orphan announced the launch of the 'hVIVO Covid Clear Test' on Thursday, its coronavirus antibody testing service, following the completion of installation, testing and training.

Read more
18 May 2020 14:11

Open Orphan confirms details around Covid antibody testing

(Sharecast News) - Pharmaceutical services company Open Orphan responded to an increase in its share price on Monday morning, as well as media comment over its collaboration with Quotient.

Read more
18 May 2020 10:51

UK TRADING UPDATE SUMMARY: Catenae Readies "Covid-19 Passport"

UK TRADING UPDATE SUMMARY: Catenae Readies "Covid-19 Passport"

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.